GT Biopharma (OXIA.MU) Q1 2026 Earnings

2MarConfirmed
Q1 2026
-1.9
-1.33
-0.76
-0.19

Details

Expected EPS
-0.1880736
Actual EPS
-1.8978336
Surprise EPS
-1.71
Surprise Percent
+909.09%

Description

GT Biopharma (OXIA.MU) has reported earnings of -1.8978336 per share for Q1 2026.

0 Comments

Share your thoughts